Recorded on-site at ESC Congress 2026 in Munich, Stephen Greene, MD, and Muthiah Vaduganathan, MD, MPH, discuss a late-breaking trial in transthyretin amyloid cardiomyopathy and what has changed in the new European heart failure guidelines. The conversation focuses on how clinicians should interpret the latest evidence in day-to-day practice.
Read the full article: https://www.hcplive.com/view/don-t-miss-a-beat-cardio-ttransform-and-new-hf-guidelines-at-esc-2026
Stephen Greene, MD, is an advanced heart failure specialist at Duke University School of Medicine. Muthiah Vaduganathan, MD, MPH, is a cardiologist at Brigham and Women's Hospital.
References
